Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
17.03
+0.30 (1.79%)
Nov 20, 2024, 4:00 PM EST - Market closed
Pacira BioSciences Employees
As of December 31, 2023, Pacira BioSciences had 712 total employees, including 711 full-time and 1 part-time employees. The number of employees decreased by 3 or -0.42% compared to the previous year.
Employees
712
Change (1Y)
-3
Growth (1Y)
-0.42%
Revenue / Employee
$976,063
Profits / Employee
-$127,431
Market Cap
786.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bioventus | 970 |
Cytek Biosciences | 676 |
Cronos Group | 356 |
Evolus | 273 |
Pliant Therapeutics | 158 |
CARGO Therapeutics | 116 |
PCRX News
- 6 days ago - Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee - GlobeNewsWire
- 14 days ago - Pacira Biosciences Inc. (PCRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Pacira BioSciences Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 22 days ago - Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024 - GlobeNewsWire
- 4 weeks ago - Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025 - GlobeNewsWire
- 2 months ago - Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee - GlobeNewsWire
- 2 months ago - DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders - PRNewsWire